Oncology Target Discovery
At StemCentrx / AbbVie, I worked on target discovery for antibody-drug conjugates (ADCs) targeting solid tumors (lung, ovarian, breast, pancreatic) and blood cancers, along with biomarker selection. Several molecules progressed to human testing, and the work resulted in multiple papers and patents.
I also supported Senti Biosciences with contract work on target discovery for CAR-T therapies. One of those programs, SENTI-202, entered human clinical trials.